Sortase Conjugation Loop for Site-Specific Antibody Labeling

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for site-specific modification of proteins, particularly antibodies, face challenges such as decreased antigen-binding activity, low yields, and mixture formation due to non-specific labeling strategies, which are not economically viable for industrial-scale applications.

Innovation Solution

Introduction of a sortase conjugation loop between the C-terminal most cysteine of the middle hinge region and the CH2-domain of immunoglobulin heavy chains, enabling sortase-mediated cleavage and ligation for site-specific conjugation of antibody fragments like F(ab')2, using a sortase nucleophile with a pentaglycine motif for efficient and controlled labeling.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If lysine-labeling strategy is used to label antibodies, then labeling can be performed using abundant and easily modified residues, but antigen-binding activity significantly decreases and yields of desired 1:1 product are low

Engineering Contradiction:
Improvelabeling easeVSAvoidantigen-binding activity
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The antibody heavy chain is segmented to include a separate sortase recognition motif (LPXTG sequence) distinct from the antigen-binding regions. This allows site-specific modification at the hinge region without affecting antigen-binding sites, resolving the contradiction between ease of labeling and preservation of antigen-binding activity

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Sortase enzyme is introduced as an intermediary to mediate the conjugation reaction. The enzyme specifically recognizes the LPXTG motif and catalyzes the attachment of labels or other molecules with high precision, enabling easy manufacturing while maintaining antibody functionality through controlled, site-specific modification

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of manufacture

If lysine-labeling strategy is used, then labeling can be performed with available coupling chemistry, but mixtures of labels attached via different lysines are formed and yields are low

Engineering Contradiction:
Improvecoupling chemistry availabilityVSAvoidlabeling site specificity
Core Design Contradiction:
Ease of manufactureVSManufacturing precision

Solution Approach 1:

The antibody is engineered with a unique local quality - a sortase recognition motif (LPXTG sequence) at a specific location in the hinge region. This creates a single, defined site for labeling that differs from all other regions of the antibody, ensuring that labels are attached uniformly at one specific location rather than distributed across multiple lysine residues, thereby achieving high manufacturing precision while maintaining ease of manufacture through standard enzymatic coupling chemistry

Inventive Principle:
Principle #3Local quality

3Ease of manufacture

If traditional labeling methods are used, then labeling can be performed with simple chemistry, but the process is not economically viable for industrial-scale applications

Engineering Contradiction:
Improvelabeling simplicityVSAvoidindustrial-scale viability
Core Design Contradiction:
Ease of manufactureVSProductivity

Solution Approach 1:

The antibody molecule itself provides the sortase recognition motif that enables specific labeling. The engineered LPXTG sequence acts as a self-service feature that guides the sortase enzyme to the correct location, eliminating the need for complex protection-deprotection strategies or multiple purification steps. This self-directing capability simplifies the overall process and improves productivity for industrial-scale production by reducing manufacturing complexity while maintaining labeling precision

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for high-yield, site-specific conjugation of antibody fragments with preserved antigen-binding activity, overcoming the limitations of traditional labeling methods by providing a controlled and efficient method for industrial-scale production.

Implementation Method 1

The sortase enzyme cleaves between the residues threonine (T) and X2 (G or A). The reaction proceeds through a thioester acyl-enzyme intermediate

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 2

The ligation motif on the sortase nucleophile (also referred to as sortase substrate), i.e. the polypeptide part of the peptidoglycan that becomes attached to the substrate on the bacterial cell wall, naturally is a pentaglycine motif. The reaction proceeds through a thioester acyl-enzyme intermediate, which is resolved by the attack of an amine nucleophile from the oligoglycine, thereby covalently linking the peptidoglycan to a protein substrate

Methodology Applied
Scientific EffectNucleophilic attack: Chemical Bonding

Data Source

PatentUS11136376B2Recombinant immunoglobulin heavy chains comprising a sortase conjugation loop and conjugates thereof
Publication Date: 2021.10.05 ROCHE DIAGNOSTICS OPERATIONS INC
  • US11136376B2 patent drawing
  • US11136376B2 patent drawing
  • US11136376B2 patent drawing

AI summary

The disclosure describes a recombinant immunoglobulin heavy chain comprising a sortase conjugation loop, methods for conjugating and/or labeling such recombinant immunoglobulin heavy chains by use of the enzyme sortase and to the conjugates/labeled products obtained via the method.